Current and emerging global themes in the bioethics of regenerative medicine: the tangled web of stem cell translation

Research output: Contribution to journalArticlepeer-review

Abstract

Probably the most serious problem facing the field of regenerative medicine today is the challenge of effective translation and development of viable stem cell-based therapies. Particular concerns have been raised over the growing market in unproven cell therapies. In this article, I explore recent developments in the stem cell therapy landscape and argue that while the sale of unproven therapies undoubtedly poses ethical concerns, it must be understood as part of a larger problem at the interface between biomedicine, healthcare, publics, policy and the market. Addressing this will require a broader perspective incorporating the shifting relationships between different stakeholder groups, the global politics of research and innovation, and the evolving role of publics and patients with respect to science.
Original languageEnglish
JournalRegenerative medicine
Volume12
Issue number7
Early online date9 Nov 2017
DOIs
Publication statusE-pub ahead of print - 9 Nov 2017

Keywords

  • Stem Cells
  • Ethics
  • Regulation
  • Regenerative Medicine
  • research translation

Fingerprint

Dive into the research topics of 'Current and emerging global themes in the bioethics of regenerative medicine: the tangled web of stem cell translation'. Together they form a unique fingerprint.

Cite this